Research ArticleBasic Science Investigations
Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using 18F-Florbetaben PET
Axel Rominger, Matthias Brendel, Steffen Burgold, Kevin Keppler, Karlheinz Baumann, Guoming Xiong, Erik Mille, Franz-Josef Gildehaus, Janette Carlsen, Juli Schlichtiger, Sabrina Niedermoser, Björn Wängler, Paul Cumming, Harald Steiner, Jochen Herms, Christian Haass and Peter Bartenstein
Journal of Nuclear Medicine July 2013, 54 (7) 1127-1134; DOI: https://doi.org/10.2967/jnumed.112.114660
Axel Rominger
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Matthias Brendel
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Steffen Burgold
2Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE) Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
Kevin Keppler
2Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE) Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
Karlheinz Baumann
3F. Hoffmann-La Roche AG, pRED, Pharma Research and Early Development, DTA CNS, Basel, Switzerland
Guoming Xiong
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Erik Mille
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Franz-Josef Gildehaus
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Janette Carlsen
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Juli Schlichtiger
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Sabrina Niedermoser
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Björn Wängler
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Paul Cumming
4ABX, Radeberg, Germany
Harald Steiner
5Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University of Munich, Munich, Germany
6German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and
Jochen Herms
2Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE) Munich, Ludwig-Maximilians-University of Munich, Munich, Germany
Christian Haass
5Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University of Munich, Munich, Germany
6German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and
7Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
Peter Bartenstein
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
7Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

Data supplements
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 7
July 1, 2013
Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using 18F-Florbetaben PET
Axel Rominger, Matthias Brendel, Steffen Burgold, Kevin Keppler, Karlheinz Baumann, Guoming Xiong, Erik Mille, Franz-Josef Gildehaus, Janette Carlsen, Juli Schlichtiger, Sabrina Niedermoser, Björn Wängler, Paul Cumming, Harald Steiner, Jochen Herms, Christian Haass, Peter Bartenstein
Journal of Nuclear Medicine Jul 2013, 54 (7) 1127-1134; DOI: 10.2967/jnumed.112.114660
Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using 18F-Florbetaben PET
Axel Rominger, Matthias Brendel, Steffen Burgold, Kevin Keppler, Karlheinz Baumann, Guoming Xiong, Erik Mille, Franz-Josef Gildehaus, Janette Carlsen, Juli Schlichtiger, Sabrina Niedermoser, Björn Wängler, Paul Cumming, Harald Steiner, Jochen Herms, Christian Haass, Peter Bartenstein
Journal of Nuclear Medicine Jul 2013, 54 (7) 1127-1134; DOI: 10.2967/jnumed.112.114660
Jump to section
Related Articles
Cited By...
- Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET
- 11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-{beta} After Therapeutic Intervention
- Glitter in the Darkness? Nonfibrillar {beta}-Amyloid Plaque Components Significantly Impact the {beta}-Amyloid PET Signal in Mouse Models of Alzheimer Disease
- Chronic PPAR{gamma} Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
- Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
- In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice
- Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-{beta} Mouse Model
- Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism
- Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study
- Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models